pentosidine has been researched along with Ventricular Dysfunction, Left in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brunner-La Rocca, HP; Dekker, JM; Henry, RM; Linssen, PB; Nijpels, G; Schalkwijk, CG; Stehouwer, CD | 1 |
| Braun, M; Celec, P; Halčák, L; Hodosy, J; Holzerová, J; Janega, P; Jáni, P; Kalousová, M; Kúdela, M; Murín, J; Parrák, V; Pecháň, I; Šebeková, K; Zima, T | 1 |
2 other study(ies) available for pentosidine and Ventricular Dysfunction, Left
| Article | Year |
|---|---|
Serum advanced glycation endproducts are associated with left ventricular dysfunction in normal glucose metabolism but not in type 2 diabetes: The Hoorn Study.
Topics: Aged; Arginine; Biomarkers; Blood Glucose; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Echocardiography; Female; Glycation End Products, Advanced; Humans; Linear Models; Lysine; Male; Middle Aged; Myocardial Contraction; Netherlands; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
Advanced glycation end products in myocardial reperfusion injury.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Animals; Arginine; Cardiac Surgical Procedures; Disease Models, Animal; Fasting; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion Injury; Neopterin; Rabbits; Stroke Volume; Thrombolytic Therapy; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Young Adult | 2012 |